INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 72 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $234,000 | -34.1% | 1,498 | 0.0% | 0.04% | -15.6% |
| Q3 2014 | $355,000 | +11.3% | 1,498 | +11.1% | 0.04% | +32.4% |
| Q2 2014 | $319,000 | -58.7% | 1,348 | -42.5% | 0.03% | -61.8% |
| Q1 2014 | $773,000 | +130.1% | 2,344 | -52.3% | 0.09% | +107.0% |
| Q4 2013 | $336,000 | -0.9% | 4,917 | 0.0% | 0.04% | -21.8% |
| Q3 2013 | $339,000 | – | 4,917 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |